Peer Support Intervention for Caregivers of Patients Undergoing HSCT
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBrigham and Women's Hospital
About this trial
The main purpose of this study is to determine if a tailored peer support intervention (STEPP-Care) is feasible among caregivers of patients undergoing hematopoietic stem cell transplantation (HSCT).
Eligibility criteria
Qualifiers
Adult caregivers (≥18 years of age) of patients with hematologic malignancies who are undergoing autologous or allogeneic HSCT at Dana-Farber Cancer Institute.
Is a relative or friend who is identified by the patient to be their caregiver.
Ability to speak, read, and respond in English
Has access to a phone.
Disqualifiers
Caregivers with acute or unstable psychiatric conditions or other cognitive conditions that the treating oncologist believes would prohibit informed consent or ability to adhere to study procedures.
Trial design
Treatments tested in this trial
- STEPP-Care
Treatment groups
90 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
Brigham and Women's Hospital
Lead sponsor
Source ClinicalTrials.gov